Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Efanesoctocog alfa in Hemophilia A: NCT06716814 Clinical Landscape Report 2026
18 September 2026
NCT06716814 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lonoctocog alfa in Hemophilia A: NCT06738485 Clinical Landscape Report 2026
18 September 2026
NCT06738485 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
SKP-0141 in Hemophilia A: NCT06738901 Clinical Landscape Report 2026
18 September 2026
NCT06738901 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Remibrutinib in Myasthenia Gravis: NCT06744920 Clinical Landscape Report 2026
18 September 2026
NCT06744920 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Armocibart in Hemophilia B: NCT06747416 Clinical Landscape Report 2026
18 September 2026
NCT06747416 clinical landscape for Hemophilia B: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Efanesoctocog alfa in Hemophilia A: NCT06752850 Clinical Landscape Report 2026
18 September 2026
NCT06752850 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Semaglutide (Novo Nordisk) in Metabolic Dysfunction Associated Steatohepatitis: NCT06764056 Clinical Landscape Report 2026
18 September 2026
NCT06764056 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Tocilizumab in Acute Chest Syndrome: NCT06818266 Clinical Landscape Report 2026
18 September 2026
NCT06818266 clinical landscape for Acute Chest Syndrome: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
GC-012F in Myasthenia Gravis: NCT06759948 Clinical Landscape Report 2026
18 September 2026
NCT06759948 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HSK-44459 in Idiopathic Pulmonary Fibrosis: NCT06764862 Clinical Landscape Report 2026
18 September 2026
NCT06764862 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Rosuvastatin Calcium in Thalassemia: NCT06813924 Clinical Landscape Report 2026
18 September 2026
NCT06813924 clinical landscape for Thalassemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HRS-9813 in Idiopathic Pulmonary Fibrosis: NCT06821464 Clinical Landscape Report 2026
18 September 2026
NCT06821464 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.